SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 13th, 2020 • Zomedica Pharmaceuticals Corp. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 13th, 2020 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of February 12, 2020, between Zomedica Pharmaceuticals Corp., an Alberta corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
COMMON SHARE PURCHASE WARRANT Zomedica Pharmaceuticals Corp.Zomedica Pharmaceuticals Corp. • February 13th, 2020 • Pharmaceutical preparations
Company FiledFebruary 13th, 2020 IndustryTHIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the six (6) month anniversary of the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______________[1] (the “Termination Date”), but not thereafter, to subscribe for and purchase from Zomedica Pharmaceuticals Corp., an Alberta corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common shares (the “Common Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).